Latent tuberculosis infection (LTBI) is a subclinical mycobacterial infection defined on the basis of cellular immune response to mycobacterial antigens. The tuberculin skin test (TST) and the interferon gamma release assay (IGRA) are currently used to establish the diagnosis of LTB.
This report contains market size and forecasts of Latent TB Detection in Global, including the following market information:
Global Latent TB Detection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Latent TB Detection market was valued at 1436.4 million in 2021 and is projected to reach US$ 2029.6 million by 2028, at a CAGR of 5.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tuberculin Skin Test (TST) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Latent TB Detection include QIAGEN, BioMeriux S.A., F. Hoffmann La-Roche Ltd., BD, ARKRAY, Inc., Abbott, Serum Institute of India Pvt. Ltd, Oxford Immunotec Ltd and Lionex GmbH. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Latent TB Detection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Latent TB Detection Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Latent TB Detection Market Segment Percentages, by Type, 2021 (%)
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Global Latent TB Detection Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Latent TB Detection Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Centers
Laboratories
Others
Global Latent TB Detection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Latent TB Detection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Latent TB Detection revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Latent TB Detection revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
QIAGEN
BioMeriux S.A.
F. Hoffmann La-Roche Ltd.
BD
ARKRAY, Inc.
Abbott
Serum Institute of India Pvt. Ltd
Oxford Immunotec Ltd
Lionex GmbH